From: Morbidity and mortality of nonagenarians undergoing CoreValve implantation
Parameter | |
---|---|
Procedural success, n (%) | 11 (100) |
Conversion to surgical AVR, n (%) | 0 (0) |
Intraprocedural circulatory depression, n (%) | 1 (9.1) |
Catecholamine therapy, n (%) | 1 (9.1) |
Resuscitation, n (%) | 1 (9.1) |
Defibrillation, n (%) | 1 (9.1) |
Vascular access site complication requiring surgery, n (%) | 1 (9.1) |
Contrast agent (ml) | 120.9 ± 44.7 |
Procedure time (min) | 110.3 ± 29.5 |
Fluoroscopy time (min) | 16.0 ± 6.8 |
CoreValve size (mm) | |
26 | 9 (81.8) |
29 | 2 (18.2) |
Pre TAVI valvuloplasty, n (%) | 11 (100) |
Post TAVI valvuloplasty, n (%) | 5 (45.5) |
Number of inflations after TAVI (n) | 1.2 ± 0.6 |
Balloon diameter (mm) | 20.6 ± 1.8 |
Balloon length (mm) | 62.7 ± 16.8 |
Valve embolization, n (%) | 2 (18.2) |
Post TAVI aortic valve mean gradient | 5.3 ± 4.1 |
Angiographic aortic insufficiency (grade) | 0.9 ± 0.45 |
ICU stay (days) | 3.36 ± 1.9 |
Hospital stay (days) | 18.5 ± 5.4 |